ELEVATEBIO

Lobbying client · Massachusetts · filed 2025 to 2025

Cell and gene therapy.

$140,000 Reported spend

5 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 5 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (64391), not by name.

Firms hired 1

W STRATEGIES, LLC $140,000 5 filings

Reported by year 1 year

2025 $140,000 5 filings

Issues lobbied 1

Health Issues 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 3
SENATE 2

Recent filings 6 total

4T

W STRATEGIES, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · $30,000 income · posted Apr 16, 2026

View → Q4

W STRATEGIES, LLC Amended

4th Quarter (Oct 1 - Dec 31) 2025 · $30,000 income · posted Jan 20, 2026

View → Q3

W STRATEGIES, LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $40,000 income · posted Oct 15, 2025

View → Q2

W STRATEGIES, LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · $40,000 income · posted Jul 18, 2025

View → Q1

W STRATEGIES, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $30,000 income · posted Apr 18, 2025

View → RR

W STRATEGIES, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · posted Feb 20, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.